ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1396

Influence of Age on Daily Impairment, Patient Empowerment, Activation and Engagement in Patients with Sjögren’s Disease

Esra Sevimli1, Berceste Polat2, Busra Sari3, Can Akmansoy2, Burcu Aksoy4, Omur Mumcu5, Hatice Kalender3, Aysegul Avcu6, Mustafa Erdogan7, Nur Sisman8, Farida Fortune9, Gonca Mumcu10 and Nevsun Inanc7, 11Institute of Health Sciences, Marmara University, Department of Health Management, Istanbul, Turkey, 2Marmara University, Faculty of Dentistry, Istanbul, Turkey, 3Institute of Health Sciences, Marmara University, Department of Health Management, Istanbul, Turkey, 4Istanbul University-Cerrahpasa, Institute of Postgraduate Education, Department of Health Management, Istanbul, Turkey, 5Yeditepe University, Faculty of Dentistry, Istanbul, Turkey, 6Marmara University, Istanbul, Turkey, 7Marmara University, School of Medicine, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey, 8Marmara University, Faculty of Health Sciences, Istanbul, Turkey, 9Barts and The London School of Medicine and Dentistry, Centre Immunobiology and Regenerative Medicine, Queen Mary University of London, London, United Kingdom, 10Faculty of Dentistry, Istanbul Okan University, Istanbul, Turkey

Meeting: ACR Convergence 2025

Keywords: Disease Activity, Patient reported outcomes, quality of life, Sjögren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1376–1404) Sjögren’s Disease – Basic & Clinical Science Poster II: Clinical Manifestations and Health Outcomes

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Patient-centred care and improvement of daily life are the main components in chronic disease management. The aim of the study was to determine associations among age, Patient Empowerment, Engagement, and Activation status and Daily impairment in patients with Sjögren disease (SjD).

Methods: In this cross-sectional study, 164 patients with SjD (F/M: 157/7; mean age: 54.4±12.4 years, disease duration: 9.02±7.14 years) were included. Data were collected by clinical examinations and a questionnaire. The Patient Empowerment (n=7 items), Engagement (n=7 items), and Activation (n=7 items) Survey (PEEAS) scale, the 5-Level EQ-5D scale (EQ-5D-5L) for quality-of-life status (high score: good QoL status) as well as the EULAR SS Patient Reported Index (ESSPRI) score were used in the study. High scores reflected Empowered, Engaged and Active patients (7-35 points in each group) in PEEAS and good self-reported health status (0-100 mm: the best health status) whereas high score of Work Productivity and Activity Impairment (WPAI)-Daily impairment and ESSPRI score were associated with poor conditions. After preliminary analysis, moderation analysis was used to test the influence of age as a third variable (Z), on the relationship between dependent (Y; WPAI, PEEAS) and independent (X; self-reported health status) variables.

Results: Increase in age was correlated with decreases in scores of EQ-5D-5L (0.62±0.21), self-reported general health status (61.92±11.59), Empowerment, Engagement and Activation subgroups (26,65±4.33; 26.68±4.20; 25.10±6.20)(p < 0.05). Moreover, an elevated WPAI-Daily impairment score (43.59±22.20) was correlated with poorer self-reported general health status and younger age (p < 0.05). According to Moderator analysis, the negative impacts of self-reported health status (X) on WPAI-Daily impairment were stronger in young (Z) patients (p < 0.05). Similar relation was not seen for PEEAS subgroups for young patients (p >0.05).Low EQ-5D-5L score as well as elevated ESSPRI score (6.48±1.64) and long duration for ocular dryness were also associated with poor scores of Empowerment, Engagement and Activation in PEEAS scale (25.10±6.20)(p < 0.05).

Conclusion: This study highlights the relationships between age, self-reported health status, patient empowerment, engagement, and those actively patient in their management. In addition, younger individuals who have poorer health perception may experience greater impairment on a daily basis. Prolonged ocular dryness emphasizes the importance of tailored interventions to enhance patient-centred care.


Disclosures: E. Sevimli: None; B. Polat: None; B. Sari: None; C. Akmansoy: None; B. Aksoy: None; O. Mumcu: None; H. Kalender: None; A. Avcu: None; M. Erdogan: None; N. Sisman: None; F. Fortune: None; G. Mumcu: None; N. Inanc: AbbVie/Abbott, 6, Amgen, 6, Janssen, 6, Novartis, 6, Pfizer, 5, 6, Roche, 6, UCB, 6.

To cite this abstract in AMA style:

Sevimli E, Polat B, Sari B, Akmansoy C, Aksoy B, Mumcu O, Kalender H, Avcu A, Erdogan M, Sisman N, Fortune F, Mumcu G, Inanc N. Influence of Age on Daily Impairment, Patient Empowerment, Activation and Engagement in Patients with Sjögren’s Disease [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/influence-of-age-on-daily-impairment-patient-empowerment-activation-and-engagement-in-patients-with-sjogrens-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/influence-of-age-on-daily-impairment-patient-empowerment-activation-and-engagement-in-patients-with-sjogrens-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology